Skip to content
healthcare.dev

Acetazolamide

NDC 10135-830, Acetazolamide, tablet, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-830
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217197
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-830 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAZOLAMIDE125 mg/1

Pharmacologic classes

Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]

Package NDCNDC-11Package
10135-830-0110135083001100 TABLET in 1 BOTTLE (10135-830-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4a03f35d-bfcb-77ff-e063-6294a90a4f06

Use it

Look up 10135-830 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-830 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-830. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.